Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

An International Journal for Oncology and Haematology Professionals

memo - Magazine of European Medical Oncology OnlineFirst articles

09.09.2021 | case report Open Access

Immune-related hepatitis in a patient with hepatocellular carcinoma treated with nivolumab

We present a case of a male patient with advanced hepatocellular carcinoma who developed hepatic and dermatological immune-related adverse events during treatment with the immune checkpoint inhibitor nivolumab. We discuss relevant aspects …

08.09.2021 | review Open Access

Neoadjuvant versus adjuvant management of resectable pancreas cancer: A review of the literature

Neoadjuvant therapy is well-accepted in the treatment of borderline resectable and locally advanced PC, the benefit of neoadjuvant chemotherapy in patients with resectable disease, however, is currently not so clear. Here we provide an up date on …

20.08.2021 | comment

The double-edged sword of immune checkpoint inhibition in advanced staged thymic epithelial tumours

20.08.2021 | case report Open Access

Rare lung cancers—Primary pulmonary leiomyosarcoma: A case report

Primary pulmonary sarcomas (PPS) are rare mesenchymal lung cancers, which do not present clinically or radiological different to lung carcinomas. Definite PPS diagnosis can only be made by histological analysis and detailed staging examinations in …

17.08.2021 | short review Open Access

Unresectable pleural mesothelioma—hope or still an unmet medical need?

Malignant pleural mesothelioma (MPM) is a rare tumour that originates from the inner linings of the pleural cavity. The majority of cases are associated with exposure to asbestos for what was banned in the European Union in 1991. Due to the long …

Aktuelle Ausgaben

Über diese Zeitschrift

The focus of the journal "magazine of european medical oncology – memo" is to offer a professional review on current research and development in the field of hematology and oncology relevant for daily practice. Therefore, memo includes editorials and comments, peer-reviewed original reports, short reviews, case reports and controversies, articles explaining the biology of neoplasia and congress reports including qualified comments. As a European journal memo aims at highlighting the local peculiarities of various regions and at being a forum for the presentation of ongoing clinical and basic research.

memo is the Official Journal of the Central European Cooperative Oncology Group (CECOG) and The Austrian Society of Haematology and Oncology (OeGHO).

Weitere Informationen